150 related articles for article (PubMed ID: 1370668)
1. Human astrocytes express membrane cofactor protein (CD46), a regulator of complement activation.
Gordon DL; Sadlon TA; Wesselingh SL; Russell SM; Johnstone RW; Purcell DF
J Neuroimmunol; 1992 Feb; 36(2-3):199-208. PubMed ID: 1370668
[TBL] [Abstract][Full Text] [Related]
2. Human CD46 rather than CD55 is a key element in protection against complement activation in vitro.
van Dixhoorn MG; Dekker S; Janssen RW; Verbakel CA; Grosveld F
Transplant Proc; 2000 Aug; 32(5):916-8. PubMed ID: 10936272
[No Abstract] [Full Text] [Related]
3. Expression of decay-accelerating factor (CD55), membrane cofactor protein (CD46) and CD59 in the human astroglioma cell line, D54-MG, and primary rat astrocytes.
Yang C; Jones JL; Barnum SR
J Neuroimmunol; 1993 Sep; 47(2):123-32. PubMed ID: 7690370
[TBL] [Abstract][Full Text] [Related]
4. Complement expression on astrocytes and astrocytoma cell lines: failure of complement regulation at the C3 level correlates with very low CD55 expression.
Spiller OB; Moretto G; Kim SU; Morgan BP; Devine DV
J Neuroimmunol; 1996 Dec; 71(1-2):97-106. PubMed ID: 8982108
[TBL] [Abstract][Full Text] [Related]
5. The expression of the complement regulators CD46, CD55, and CD59 by human sperm does not protect them from antisperm antibody- and complement-mediated immune injury.
D'Cruz OJ; Haas GG
Fertil Steril; 1993 Apr; 59(4):876-84. PubMed ID: 7681414
[TBL] [Abstract][Full Text] [Related]
6. Alternatively spliced RNAs encode several isoforms of CD46 (MCP), a regulator of complement activation.
Purcell DF; Russell SM; Deacon NJ; Brown MA; Hooker DJ; McKenzie IF
Immunogenetics; 1991; 33(5-6):335-44. PubMed ID: 2050389
[TBL] [Abstract][Full Text] [Related]
7. High expression of membrane cofactor protein of complement (CD46) in human leukaemia cell lines: implication of an alternatively spliced form containing the STA domain in CD46 up-regulation.
Hara T; Suzuki Y; Semba T; Hatanaka M; Matsumoto M; Seya T
Scand J Immunol; 1995 Dec; 42(6):581-90. PubMed ID: 8552981
[TBL] [Abstract][Full Text] [Related]
8. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
Goslings WR; Blom DJ; de Waard-Siebinga I; van Beelen E; Claas FH; Jager MJ; Gorter A
Invest Ophthalmol Vis Sci; 1996 Aug; 37(9):1884-91. PubMed ID: 8759358
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation by interferon-gamma of the membrane-bound complement regulators CD46 (MCP), CD55 (DAF) and CD59 in gastrointestinal tumours.
Schmitt CA; Schwaeble W; Wittig BM; Meyer zum Büschenfelde KH; Dippold WG
Eur J Cancer; 1999 Jan; 35(1):117-24. PubMed ID: 10211099
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region.
Nomura M; Kurita-Taniguchi M; Kondo K; Inoue N; Matsumoto M; Yamanishi K; Okabe M; Seya T
Eur J Immunol; 2002 Oct; 32(10):2954-64. PubMed ID: 12355449
[TBL] [Abstract][Full Text] [Related]
11. Protection of thyroid cancer cells by complement-regulatory factors.
Yamakawa M; Yamada K; Tsuge T; Ohrui H; Ogata T; Dobashi M; Imai Y
Cancer; 1994 Jun; 73(11):2808-17. PubMed ID: 7514955
[TBL] [Abstract][Full Text] [Related]
12. Expression of complement regulatory proteins [membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59)] in endometrial stressed cells.
Iborra A; Mayorga M; Llobet N; Martínez P
Cell Immunol; 2003 May; 223(1):46-51. PubMed ID: 12914757
[TBL] [Abstract][Full Text] [Related]
13. Complement activation and regulator expression after anoxic injury of human endothelial cells.
Väkevä A; Meri S
APMIS; 1998 Dec; 106(12):1149-56. PubMed ID: 10052723
[TBL] [Abstract][Full Text] [Related]
14. Chimeric CD46/DAF molecules reveal a cryptic functional role for SCR1 of DAF in regulating complement activation.
Christiansen D; Loveland B; Kyriakou P; Lanteri M; Rubinstein E; Gerlier D
Mol Immunol; 2000; 37(12-13):687-96. PubMed ID: 11275254
[TBL] [Abstract][Full Text] [Related]
15. Identification of the streptococcal M protein binding site on membrane cofactor protein (CD46).
Giannakis E; Jokiranta TS; Ormsby RJ; Duthy TG; Male DA; Christiansen D; Fischetti VA; Bagley C; Loveland BE; Gordon DL
J Immunol; 2002 May; 168(9):4585-92. PubMed ID: 11971006
[TBL] [Abstract][Full Text] [Related]
16. Effects of complement activation products on the synthesis of decay accelerating factor and membrane cofactor protein by human mesangial cells.
Cosio FG; Shibata T; Rovin BH; Birmingham DJ
Kidney Int; 1994 Oct; 46(4):986-92. PubMed ID: 7532249
[TBL] [Abstract][Full Text] [Related]
17. Complement-binding proteins are strongly expressed by human preimplantation blastocysts and cumulus cells as well as gametes.
Taylor CT; Johnson PM
Mol Hum Reprod; 1996 Jan; 2(1):52-9. PubMed ID: 9238658
[TBL] [Abstract][Full Text] [Related]
18. Aberrant expression of complement regulatory proteins, membrane cofactor protein and decay accelerating factor, in the involved epidermis of patients with vitiligo.
van den Wijngaard RM; Asghar SS; Pijnenborg AC; Tigges AJ; Westerhof W; Das PK
Br J Dermatol; 2002 Jan; 146(1):80-7. PubMed ID: 11841370
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of CD55 and CD46 expression by anti-sense phosphorothioate oligonucleotides (S-ODNs) sensitizes tumour cells to complement attack.
Zell S; Geis N; Rutz R; Schultz S; Giese T; Kirschfink M
Clin Exp Immunol; 2007 Dec; 150(3):576-84. PubMed ID: 17903221
[TBL] [Abstract][Full Text] [Related]
20. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]